Novartis AG:企業のM&A・事業提携・投資動向

◆英語タイトル:Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2102
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:980
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Novartis AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Novartis AG since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Novartis AG’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Novartis AG. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Novartis AG’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Novartis AG and its subsidiaries since 2007.
- Information about key financial and legal advisors for Novartis AG’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Novartis AG’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 10
Mergers and Acquisitions – Overview 10
Mergers and Acquisitions – Deal reports 11
CORPORATE VENTURING 96
Corporate Venturing – Overview 96
Corporate Venturing – Deal reports 97
PARTNERSHIP 162
Partnership – Overview 162
Partnership – Deal reports 163
DIVESTMENTS 891
Divestments – Overview 891
Divestments – Deal reports 892
PRIVATE EQUITY & OWNERSHIP 968
Private Equity and Ownership – Deal reports 968
APPENDIX 970
Contact Us 970
About MarketLine Financial Deals Database 970
Deal Definition and Methodology 972
About MarketLine 979

List of Tables
Table 1: Novartis AG M&A volume and value trend (2014-YTD2018)
Table 2: Novartis AG M&A activity by geography (2014-YTD2018)
Table 3: Novartis AG corporate venturing volume and value trend (2014-YTD2018)
Table 4: Novartis AG corporate venturing by geography (2014-YTD2018)
Table 5: Novartis AG partnership volume and value trend (2014-YTD2018)
Table 6: Novartis AG partnership trend by key deal type (2014-YTD2018)
Table 7: Novartis AG divestments volume and value trend (2014-YTD2018)
Table 8: Novartis AG divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Novartis AG M&A volume and value trend (2014-YTD2018)
Figure 2: Novartis AG M&A activity by geography (2014-YTD2018)
Figure 3: Novartis AG corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Novartis AG corporate venturing by geography (2014-YTD2018)
Figure 5: Novartis AG partnership volume and value trend (2014-YTD2018)
Figure 6: Novartis AG partnership trend by key deal type (2014-YTD2018)
Figure 7: Novartis AG divestments volume and value trend (2014-YTD2018)
Figure 8: Novartis AG divestments by geography (2014-YTD2018)

★海外企業調査レポート[Novartis AG:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Elasmogen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Elasmogen Ltd (Elasmogen), formerly Pacific Shelf 1760 Ltd, is a biopharmaceutical company which focuses on the development of soloMER products for the treatment of auto-inflammatory diseases, ophthalmology, oncology and intracellular delivery. soloMERs are proprietary humanized clinical can …
  • Nippon Shinyaku Co Ltd (4516):企業の財務・戦略的SWOT分析
    Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Horizon Oil Ltd (HZN):石油・ガス:M&Aディール及び事業提携情報
    Summary Horizon Oil Ltd (Horizon) is an oil and gas exploration and production company that acquires, explores, develops and produces oil and petroleum properties. The company holds interests in Maari and Manaia fields located in the Taranaki Basin approximately 80 kilometre offshore the north islan …
  • Texas Roadhouse Inc (TXRH):企業の財務・戦略的SWOT分析
    Texas Roadhouse Inc (TXRH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Rex Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Rex Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Rex Energy Corp (Rex Energy) is an independent energy company. It carries out the acquisition, production, exploration and development of condensate, natural gas and natural gas liquids. It holds pro …
  • Delaware Electric Cooperative Inc:企業の戦略的SWOT分析
    Delaware Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Shima Seiki Mfg Ltd (6222):企業の財務・戦略的SWOT分析
    Shima Seiki Mfg Ltd (6222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Heerema International Group Services SA:企業の戦略的SWOT分析
    Heerema International Group Services SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Ion Beam Applications SA (IBAB):医療機器:M&Aディール及び事業提携情報
    Summary Ion Beam Applications SA (IBA) develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses its activities on proton therapy solut …
  • Fujirebio Diagnostics Inc:企業の製品パイプライン分析
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …
  • PayPal Holdings, Inc.:企業のM&A・事業提携・投資動向
    PayPal Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PayPal Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that offers laboratory services. The laboratory’s services include picogram-level bioanalytical method development and validation, analytical and bioanalytical support for ADME studies, and analytical and bioanalytical support for pharma …
  • Industrias Penoles SAB de CV:戦略・SWOT・企業財務分析
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務分析
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Univar Inc (UNVR):企業の財務・戦略的SWOT分析
    Univar Inc (UNVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cairn Energy Plc (CNE):企業の財務・戦略的SWOT分析
    Cairn Energy Plc (CNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bioneer Corp (064550):企業の財務・戦略的SWOT分析
    Bioneer Corp (064550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Rheonix Inc:企業の製品パイプライン分析2018
    Summary Rheonix Inc (Rheonix) is a medical equipment company that develops molecular diagnostic products. The company offers automated and integrated molecular testing device. It develops Rheonix CARD cartridge technology which penetrates molecular testing markets from diagnostics labs to applied ma …
  • Breville Group Ltd (BRG):企業の財務・戦略的SWOT分析
    Breville Group Ltd (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Getlink SE:企業の戦略・SWOT・財務分析
    Getlink SE - Strategy, SWOT and Corporate Finance Report Summary Getlink SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆